Haisco Pharmaceutical (SHE:002653) obtained approval from China's National Medical Products Administration for the clinical trials of the HSK44459 cream, according to a Wednesday filing on the Shenzhen bourse.
The cream will be tested as a treatment for psoriasis and atopic dermatitis.
Star Sports Medicine (HKG:1609) subscribed to two wealth management products with a combined principal amount of 190 million yuan, according to a Tuesday Hong Kong bourse filing.Shares of the medical device company were up nearly 3% in Wednesday afternoon trade.The company subscribed to an 80 million yuan wealth management product issued by Agricultural Bank of China (HKG:1288, SHA:601288) on May 26 and a 110 million yuan product issued by Bank of Beijing on May 11, using its own funds.The company said the subscriptions were part of its routine treasury management of idle funds and followed the maturity of earlier wealth management and structured deposit investments this month.
Guangzhou Tinci Materials Technology (SHE:002709), through subsidiary Tinci Materials (Taizhou), will construct a high-pressure lithium iron phosphate plant for up to 2.10 billion yuan, according to a Shenzhen bourse filing on Wednesday.The plant will annually produce 160,000 tons of lithium iron phosphate.The Chinese new energy material manufacturer's shares rose 2% during the afternoon trade.
SANA Lifestyles, a wholly-owned subsidiary of Stanley Lifestyles (NSE:STANLEY, BOM:544202), has secured an order worth around 2 million Indian rupees from the Reserve Bank of India, according to a statement to the Indian stock exchanges on Wednesday.The contract is for the supply and installation of sofas and allied furniture products at RBI Chennai's main office.The order is expected to be completed in seven weeks.The company's shares were down nearly 1% in recent trade.